Sankyo launches angiontensin II antagonist/diuretic combination

Sankyo Pharma has launched Olmetec Plus, a fixed dose combination of the angiotensin II antagonist olmesartan, and the thiazide diuretic hydrochlorothiazide, for the treatment of hypertension in patients whose blood pressure is not adequately controlled by olmesartan alone.

Olmetec Plus is available in two strengths - 20 mg/12.5 mg and 20mg/25 mg - each containing 20mg olmesartan medoxomil and either 12.5 mg or 25 mg hydrochlorothiazide.

Olmetec Plus is not indicated for use in initial therapy of hypertension. Patients inadequately controlled by olmesartan alone should be started on Olmetec Plus 20mg/12.5 mg once daily, increasing to Olmetec Plus 20mg/25mg if blood pressure is still not adequately controlled.

Both strengths of Olmetec Plus are presented in packs of 28 tablets and have the same basic NHS price of £12.95.

Further information: Sankyo Pharma UK Ltd, Repton Place, White Lion Road, Amersham, Bucks, HP7 9LP. Tel: (01494) 766866.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases